Ulrike Naumann

1.1k total citations
20 papers, 457 citations indexed

About

Ulrike Naumann is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ulrike Naumann has authored 20 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Ulrike Naumann's work include Management of metastatic bone disease (5 papers), CRISPR and Genetic Engineering (3 papers) and Spinal Fractures and Fixation Techniques (3 papers). Ulrike Naumann is often cited by papers focused on Management of metastatic bone disease (5 papers), CRISPR and Genetic Engineering (3 papers) and Spinal Fractures and Fixation Techniques (3 papers). Ulrike Naumann collaborates with scholars based in Switzerland, Germany and United Kingdom. Ulrike Naumann's co-authors include Benjamin Ulmar, Heiko Reichel, K. Huch, Annick Waldt, Rachel Cuttat, Guglielmo Roma, Rajiv Kumar, Michela Guardascione, David Lorente and Elena Geuna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Ulrike Naumann

19 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Naumann Switzerland 11 153 124 122 121 81 20 457
Daniel Heudobler Germany 13 87 0.6× 188 1.5× 44 0.4× 185 1.5× 70 0.9× 45 426
Qi Cai China 11 45 0.3× 146 1.2× 40 0.3× 60 0.5× 79 1.0× 25 378
Aaron C. Haran United States 5 52 0.3× 159 1.3× 31 0.3× 52 0.4× 35 0.4× 6 411
Li Zuo China 13 73 0.5× 252 2.0× 23 0.2× 93 0.8× 110 1.4× 35 451
Cuihong Wei Canada 8 22 0.1× 118 1.0× 36 0.3× 147 1.2× 89 1.1× 16 368
Michal Beránek Czechia 13 29 0.2× 131 1.1× 63 0.5× 54 0.4× 40 0.5× 18 457
Paul Basciano United States 11 121 0.8× 96 0.8× 40 0.3× 115 1.0× 108 1.3× 26 523
Jianbo Ma China 7 49 0.3× 119 1.0× 29 0.2× 56 0.5× 205 2.5× 10 418
Lucie Coppin France 14 52 0.3× 177 1.4× 43 0.4× 140 1.2× 59 0.7× 25 421
Alejandro Ferrer United States 10 106 0.7× 88 0.7× 12 0.1× 73 0.6× 38 0.5× 27 365

Countries citing papers authored by Ulrike Naumann

Since Specialization
Citations

This map shows the geographic impact of Ulrike Naumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Naumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Naumann more than expected).

Fields of papers citing papers by Ulrike Naumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Naumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Naumann. The network helps show where Ulrike Naumann may publish in the future.

Co-authorship network of co-authors of Ulrike Naumann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Naumann. A scholar is included among the top collaborators of Ulrike Naumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Naumann. Ulrike Naumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Benoit, Tara Alpert, Martin Beibel, et al.. (2025). SACF and GILA assays on AML12 cells show limited predictive value for mouse liver genotoxicity. Toxicology and Applied Pharmacology. 504. 117529–117529.
2.
Mermet‐Meillon, Fanny, Judith Knehr, Ulrike Naumann, et al.. (2024). Protein destabilization underlies pathogenic missense mutations in ARID1B. Nature Structural & Molecular Biology. 31(7). 1018–1022. 4 indexed citations
3.
Bruccoleri, Robert E., et al.. (2023). Genome assembly of the bearded iris, Iris pallida Lam.. SHILAP Revista de lepidopterología. 2023. 1–10. 2 indexed citations
4.
Solovyeva, Elizaveta M., Erik Ahrné, E.A. Hermes, et al.. (2023). Integrative Proteogenomics for Differential Expression and Splicing Variation in a DM1 Mouse Model. Molecular & Cellular Proteomics. 23(1). 100683–100683. 2 indexed citations
5.
Neri, Marilisa, Mario Bernhard, Irena Brzak, et al.. (2022). Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer’s disease. Cell Reports. 39(9). 110883–110883. 33 indexed citations
6.
Bégué, Damien, Valentina Cordo’, Gráinne Kerr, et al.. (2021). Therapeutic Assessment of Targeting ASNS Combined with l -Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms. ACS Pharmacology & Translational Science. 4(1). 327–337. 18 indexed citations
7.
Fischer, Benoit, Lindsey Ulkus Rodrigues, Gráinne Kerr, et al.. (2021). Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells. Molecular Therapy — Methods & Clinical Development. 23. 241–253. 12 indexed citations
8.
Solovyeva, Elizaveta M., Chikwendu Ibebunjo, John K. Eash, et al.. (2021). New insights into molecular changes in skeletal muscle aging and disease: Differential alternative splicing and senescence. Mechanisms of Ageing and Development. 197. 111510–111510. 23 indexed citations
9.
Gümüş, Mahmut, Chieh-I Chen, Cristina Ivanescu, et al.. (2021). Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 ≥ 50%: Results from EMPOWER-Lung 1 study.. Journal of Clinical Oncology. 39(15_suppl). 9078–9078. 3 indexed citations
10.
Beibel, Martin, Kea Martin, Rachel Cuttat, et al.. (2020). Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight. 5(3). 111 indexed citations
11.
Sprouffske, Kathleen, Gráinne Kerr, Anirudh Prahallad, et al.. (2020). Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models. Computational and Structural Biotechnology Journal. 18. 323–331. 21 indexed citations
12.
Vitobello, Antonio, Juliane Perner, Jiang Zhu, et al.. (2019). Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotion. Life Science Alliance. 2(5). e201900461–e201900461. 9 indexed citations
13.
Shimada, Kenji, et al.. (2018). Asymmetric Processing of DNA Ends at a Double-Strand Break Leads to Unconstrained Dynamics and Ectopic Translocation. Cell Reports. 24(10). 2614–2628.e4. 21 indexed citations
14.
Kumar, Rajiv, Elena Geuna, Vasiliki Michalarea, et al.. (2015). The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. British Journal of Cancer. 112(7). 1157–1165. 62 indexed citations
15.
Heidrich, Benjamin, Steffen B. Wiegand, J. Petersen, et al.. (2014). P1109 OVERTREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 2/3 WITH LOW BASELINE VIRAL LOAD AND RVR: EXPERIENCES IN A REAL WORLD SETTING. Journal of Hepatology. 60(1). S447–S447. 1 indexed citations
16.
Ulmar, Benjamin, et al.. (2007). Evaluation of the Tokuhashi prognosis score and its modifications in 217 patients with vertebral metastases. European Journal of Surgical Oncology. 33(7). 914–919. 51 indexed citations
17.
Ulmar, Benjamin, et al.. (2007). Evaluation and Modification of the Tomita Score in 217 Patients with Vertebral Metastases. Oncology Research and Treatment. 30(8-9). 414–418. 6 indexed citations
18.
Ulmar, Benjamin, et al.. (2007). Der prognostische Einfluss von Primärtumor und Höhe des befallenen Wirbelsäulenabschnitts bei 217 operativen Patienten mit Wirbelsäulenmetastasen unterschiedlicher Entität. Zeitschrift für Orthopädie und ihre Grenzgebiete. 145(1). 31–38. 15 indexed citations
19.
Ulmar, Benjamin, et al.. (2006). Chirurgische Therapie und Evaluation von Prognosefaktoren bei Wirbelsäulenmetastasen durch Nieren-Zell-Karzinome. Zeitschrift für Orthopädie und ihre Grenzgebiete. 144(1). 58–67. 9 indexed citations
20.
Ulmar, Benjamin, Ulrike Naumann, Rainer Muche, et al.. (2006). Prognosis Scores of Tokuhashi and Tomita for Patients With Spinal Metastases of Renal Cancer. Annals of Surgical Oncology. 14(2). 998–1004. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Heudobler Breakdown of academic impact, for papers by Qi Cai Breakdown of academic impact, for papers by Aaron C. Haran Breakdown of academic impact, for papers by Li Zuo Breakdown of academic impact, for papers by Cuihong Wei Breakdown of academic impact, for papers by Michal Beránek Breakdown of academic impact, for papers by Paul Basciano Breakdown of academic impact, for papers by Jianbo Ma Breakdown of academic impact, for papers by Lucie Coppin Breakdown of academic impact, for papers by Alejandro Ferrer
Rankless by CCL
2026